Have a feature idea you'd love to see implemented? Let us know!

CODX Co-Diagnostics Inc

Price (delayed)

$1.24

Market cap

$39.57M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.26

Enterprise value

$28.29M

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using ...

Highlights
The company's gross profit has surged by 98% QoQ and by 8% YoY
The revenue has grown by 37% from the previous quarter and by 25% YoY
Co-Diagnostics's gross margin has increased by 45% QoQ but it has decreased by 14% YoY
Co-Diagnostics's quick ratio has decreased by 38% YoY and by 10% QoQ
The equity has declined by 30% year-on-year and by 8% since the previous quarter

Key stats

What are the main financial stats of CODX
Market
Shares outstanding
31.91M
Market cap
$39.57M
Enterprise value
$28.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.54
Price to sales (P/S)
4.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.1
Earnings
Revenue
$9.14M
EBIT
-$35.81M
EBITDA
-$34.5M
Free cash flow
-$26.27M
Per share
EPS
-$1.26
Free cash flow per share
-$0.87
Book value per share
$2.31
Revenue per share
$0.3
TBVPS
$1.81
Balance sheet
Total assets
$80.7M
Total liabilities
$8.3M
Debt
$2.58M
Equity
$72.4M
Working capital
$42.91M
Liquidity
Debt to equity
0.04
Current ratio
9.09
Quick ratio
8.56
Net debt/EBITDA
0.33
Margins
EBITDA margin
-377.5%
Gross margin
59.8%
Net margin
-411.2%
Operating margin
-423.6%
Efficiency
Return on assets
-40.5%
Return on equity
-44.7%
Return on invested capital
-73.9%
Return on capital employed
-47.5%
Return on sales
-391.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CODX stock price

How has the Co-Diagnostics stock price performed over time
Intraday
1.64%
1 week
2.48%
1 month
-3.13%
1 year
-6.77%
YTD
-6.77%
QTD
-0.8%

Financial performance

How have Co-Diagnostics's revenue and profit performed over time
Revenue
$9.14M
Gross profit
$5.47M
Operating income
-$38.7M
Net income
-$37.57M
Gross margin
59.8%
Net margin
-411.2%
The company's gross profit has surged by 98% QoQ and by 8% YoY
Co-Diagnostics's gross margin has increased by 45% QoQ but it has decreased by 14% YoY
Co-Diagnostics's operating margin has increased by 43% YoY and by 34% from the previous quarter
The revenue has grown by 37% from the previous quarter and by 25% YoY

Growth

What is Co-Diagnostics's growth rate over time

Valuation

What is Co-Diagnostics stock price valuation
P/E
N/A
P/B
0.54
P/S
4.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.1
CODX's EPS is up by 4.5% since the previous quarter
The P/B is 84% below the 5-year quarterly average of 3.4 but 33% above the last 4 quarters average of 0.4
The equity has declined by 30% year-on-year and by 8% since the previous quarter
The P/S is 69% below the 5-year quarterly average of 13.1 and 26% below the last 4 quarters average of 5.4
The revenue has grown by 37% from the previous quarter and by 25% YoY

Efficiency

How efficient is Co-Diagnostics business performance
CODX's return on sales is up by 40% year-on-year and by 34% since the previous quarter
CODX's return on equity is down by 37% year-on-year and by 5% since the previous quarter
The ROA has contracted by 34% YoY and by 4.9% from the previous quarter
CODX's return on invested capital is up by 7% year-on-year but it is down by 6% since the previous quarter

Dividends

What is CODX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CODX.

Financial health

How did Co-Diagnostics financials performed over time
The current ratio has decreased by 40% YoY and by 11% from the previous quarter
Co-Diagnostics's quick ratio has decreased by 38% YoY and by 10% QoQ
The company's debt is 96% lower than its equity
The debt to equity is up by 33% year-on-year
The equity has declined by 30% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.